 | • レポートコード：QFJ1-3762 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、中毒治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アルコール依存症治療薬、タバコ依存症治療薬、薬物依存症治療薬）、用途別市場規模（公共用、民間用、政府）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・中毒治療薬の市場動向 ・企業の競争状況、市場シェア ・中毒治療薬の種類別市場規模と予測2016-2027（アルコール依存症治療薬、タバコ依存症治療薬、薬物依存症治療薬） ・中毒治療薬の用途別市場規模と予測2016-2027（公共用、民間用、政府） ・中毒治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・中毒治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・中毒治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・中毒治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・中毒治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Alkermes Plc、Amneal Pharmaceuticals Inc.、Indivior Plc、Johnson & Johnson Services Inc.、Mylan NV、Novartis AG、Novo Nordisk AS、Opiant Pharmaceuticals Inc.、Pfizer Inc.、Teva Pharmaceutical Industries Ltd.） ・結論 |
Addiction is a brain disorder characterized by compulsive engagement in rewarding stimuli despite adverse consequences.Despite the involvement of a number of psychosocial factors, a biological process – one which is induced by repeated exposure to an addictive stimulus – is the core pathology that drives the development and maintenance of an addiction.
With the rising alcohol, opioid, and tobacco addiction across the world, many public, private, and government organizations are conducting programs to increase awareness about substance abuse and its health implications. For instance, the Substance Abuse and Mental Health Services Administration (SAMHSA) in the US sponsors the Recovery Month to increase awareness about mental and substance use disorders and celebrate recovery. The organization also offers services to people with substance use disorders. Also, in countries such as India, government bodies provide financial assistance to many NGOs and urban local agencies to carry out combines services to spread awareness and rehabilitate individuals with addiction disorders.
Market Analysis and Insights: Global Addictions Therapeutics Market
The global Addictions Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Addictions Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Addictions Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Addictions Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Addictions Therapeutics market.
Global Addictions Therapeutics Scope and Market Size
Addictions Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Addictions Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Alcohol Addiction Therapeutics
Tobacco Addiction Therapeutics
Drug Addiction Therapeutics
Segment by Application
Public
Private
Government
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Alkermes Plc
Amneal Pharmaceuticals Inc.
Indivior Plc
Johnson & Johnson Services Inc.
Mylan NV
Novartis AG
Novo Nordisk AS
Opiant Pharmaceuticals Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Addictions Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Alcohol Addiction Therapeutics
1.2.3 Tobacco Addiction Therapeutics
1.2.4 Drug Addiction Therapeutics
1.3 Market by Application
1.3.1 Global Addictions Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Public
1.3.3 Private
1.3.4 Government
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Addictions Therapeutics Market Perspective (2016-2027)
2.2 Addictions Therapeutics Growth Trends by Regions
2.2.1 Addictions Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Addictions Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Addictions Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Addictions Therapeutics Industry Dynamic
2.3.1 Addictions Therapeutics Market Trends
2.3.2 Addictions Therapeutics Market Drivers
2.3.3 Addictions Therapeutics Market Challenges
2.3.4 Addictions Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Addictions Therapeutics Players by Revenue
3.1.1 Global Top Addictions Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Addictions Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Addictions Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Addictions Therapeutics Revenue
3.4 Global Addictions Therapeutics Market Concentration Ratio
3.4.1 Global Addictions Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Addictions Therapeutics Revenue in 2020
3.5 Addictions Therapeutics Key Players Head office and Area Served
3.6 Key Players Addictions Therapeutics Product Solution and Service
3.7 Date of Enter into Addictions Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Addictions Therapeutics Breakdown Data by Type
4.1 Global Addictions Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Addictions Therapeutics Forecasted Market Size by Type (2022-2027)
5 Addictions Therapeutics Breakdown Data by Application
5.1 Global Addictions Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Addictions Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Addictions Therapeutics Market Size (2016-2027)
6.2 North America Addictions Therapeutics Market Size by Type
6.2.1 North America Addictions Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Addictions Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Addictions Therapeutics Market Size by Type (2016-2027)
6.3 North America Addictions Therapeutics Market Size by Application
6.3.1 North America Addictions Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Addictions Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Addictions Therapeutics Market Size by Application (2016-2027)
6.4 North America Addictions Therapeutics Market Size by Country
6.4.1 North America Addictions Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Addictions Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Addictions Therapeutics Market Size (2016-2027)
7.2 Europe Addictions Therapeutics Market Size by Type
7.2.1 Europe Addictions Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Addictions Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Addictions Therapeutics Market Size by Type (2016-2027)
7.3 Europe Addictions Therapeutics Market Size by Application
7.3.1 Europe Addictions Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Addictions Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Addictions Therapeutics Market Size by Application (2016-2027)
7.4 Europe Addictions Therapeutics Market Size by Country
7.4.1 Europe Addictions Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Addictions Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Addictions Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Addictions Therapeutics Market Size by Type
8.2.1 Asia-Pacific Addictions Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Addictions Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Addictions Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Addictions Therapeutics Market Size by Application
8.3.1 Asia-Pacific Addictions Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Addictions Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Addictions Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Addictions Therapeutics Market Size by Region
8.4.1 Asia-Pacific Addictions Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Addictions Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Addictions Therapeutics Market Size (2016-2027)
9.2 Latin America Addictions Therapeutics Market Size by Type
9.2.1 Latin America Addictions Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Addictions Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Addictions Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Addictions Therapeutics Market Size by Application
9.3.1 Latin America Addictions Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Addictions Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Addictions Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Addictions Therapeutics Market Size by Country
9.4.1 Latin America Addictions Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Addictions Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Addictions Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Addictions Therapeutics Market Size by Type
10.2.1 Middle East & Africa Addictions Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Addictions Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Addictions Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Addictions Therapeutics Market Size by Application
10.3.1 Middle East & Africa Addictions Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Addictions Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Addictions Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Addictions Therapeutics Market Size by Country
10.4.1 Middle East & Africa Addictions Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Addictions Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alkermes Plc
11.1.1 Alkermes Plc Company Details
11.1.2 Alkermes Plc Business Overview
11.1.3 Alkermes Plc Addictions Therapeutics Introduction
11.1.4 Alkermes Plc Revenue in Addictions Therapeutics Business (2016-2021)
11.1.5 Alkermes Plc Recent Development
11.2 Amneal Pharmaceuticals Inc.
11.2.1 Amneal Pharmaceuticals Inc. Company Details
11.2.2 Amneal Pharmaceuticals Inc. Business Overview
11.2.3 Amneal Pharmaceuticals Inc. Addictions Therapeutics Introduction
11.2.4 Amneal Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2016-2021)
11.2.5 Amneal Pharmaceuticals Inc. Recent Development
11.3 Indivior Plc
11.3.1 Indivior Plc Company Details
11.3.2 Indivior Plc Business Overview
11.3.3 Indivior Plc Addictions Therapeutics Introduction
11.3.4 Indivior Plc Revenue in Addictions Therapeutics Business (2016-2021)
11.3.5 Indivior Plc Recent Development
11.4 Johnson & Johnson Services Inc.
11.4.1 Johnson & Johnson Services Inc. Company Details
11.4.2 Johnson & Johnson Services Inc. Business Overview
11.4.3 Johnson & Johnson Services Inc. Addictions Therapeutics Introduction
11.4.4 Johnson & Johnson Services Inc. Revenue in Addictions Therapeutics Business (2016-2021)
11.4.5 Johnson & Johnson Services Inc. Recent Development
11.5 Mylan NV
11.5.1 Mylan NV Company Details
11.5.2 Mylan NV Business Overview
11.5.3 Mylan NV Addictions Therapeutics Introduction
11.5.4 Mylan NV Revenue in Addictions Therapeutics Business (2016-2021)
11.5.5 Mylan NV Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Details
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Addictions Therapeutics Introduction
11.6.4 Novartis AG Revenue in Addictions Therapeutics Business (2016-2021)
11.6.5 Novartis AG Recent Development
11.7 Novo Nordisk AS
11.7.1 Novo Nordisk AS Company Details
11.7.2 Novo Nordisk AS Business Overview
11.7.3 Novo Nordisk AS Addictions Therapeutics Introduction
11.7.4 Novo Nordisk AS Revenue in Addictions Therapeutics Business (2016-2021)
11.7.5 Novo Nordisk AS Recent Development
11.8 Opiant Pharmaceuticals Inc.
11.8.1 Opiant Pharmaceuticals Inc. Company Details
11.8.2 Opiant Pharmaceuticals Inc. Business Overview
11.8.3 Opiant Pharmaceuticals Inc. Addictions Therapeutics Introduction
11.8.4 Opiant Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2016-2021)
11.8.5 Opiant Pharmaceuticals Inc. Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Details
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. Addictions Therapeutics Introduction
11.9.4 Pfizer Inc. Revenue in Addictions Therapeutics Business (2016-2021)
11.9.5 Pfizer Inc. Recent Development
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Company Details
11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.10.3 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Introduction
11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Addictions Therapeutics Business (2016-2021)
11.10.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Addictions Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Alcohol Addiction Therapeutics
Table 3. Key Players of Tobacco Addiction Therapeutics
Table 4. Key Players of Drug Addiction Therapeutics
Table 5. Global Addictions Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Addictions Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Addictions Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Addictions Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Addictions Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Addictions Therapeutics Market Share by Regions (2022-2027)
Table 11. Addictions Therapeutics Market Trends
Table 12. Addictions Therapeutics Market Drivers
Table 13. Addictions Therapeutics Market Challenges
Table 14. Addictions Therapeutics Market Restraints
Table 15. Global Addictions Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Addictions Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Addictions Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Addictions Therapeutics as of 2020)
Table 18. Ranking of Global Top Addictions Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Addictions Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Addictions Therapeutics Product Solution and Service
Table 22. Date of Enter into Addictions Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Addictions Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Addictions Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Addictions Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Addictions Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Addictions Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Addictions Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Addictions Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Addictions Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Addictions Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Addictions Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Addictions Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Addictions Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Addictions Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Addictions Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Addictions Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Addictions Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Addictions Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Addictions Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Addictions Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Addictions Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Addictions Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Addictions Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Addictions Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Addictions Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Addictions Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Addictions Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Addictions Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Addictions Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Addictions Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Addictions Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Addictions Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Addictions Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Addictions Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Addictions Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Addictions Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Addictions Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Addictions Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Addictions Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Alkermes Plc Company Details
Table 63. Alkermes Plc Business Overview
Table 64. Alkermes Plc Addictions Therapeutics Product
Table 65. Alkermes Plc Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Alkermes Plc Recent Development
Table 67. Amneal Pharmaceuticals Inc. Company Details
Table 68. Amneal Pharmaceuticals Inc. Business Overview
Table 69. Amneal Pharmaceuticals Inc. Addictions Therapeutics Product
Table 70. Amneal Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Amneal Pharmaceuticals Inc. Recent Development
Table 72. Indivior Plc Company Details
Table 73. Indivior Plc Business Overview
Table 74. Indivior Plc Addictions Therapeutics Product
Table 75. Indivior Plc Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Indivior Plc Recent Development
Table 77. Johnson & Johnson Services Inc. Company Details
Table 78. Johnson & Johnson Services Inc. Business Overview
Table 79. Johnson & Johnson Services Inc. Addictions Therapeutics Product
Table 80. Johnson & Johnson Services Inc. Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Johnson & Johnson Services Inc. Recent Development
Table 82. Mylan NV Company Details
Table 83. Mylan NV Business Overview
Table 84. Mylan NV Addictions Therapeutics Product
Table 85. Mylan NV Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Mylan NV Recent Development
Table 87. Novartis AG Company Details
Table 88. Novartis AG Business Overview
Table 89. Novartis AG Addictions Therapeutics Product
Table 90. Novartis AG Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Novartis AG Recent Development
Table 92. Novo Nordisk AS Company Details
Table 93. Novo Nordisk AS Business Overview
Table 94. Novo Nordisk AS Addictions Therapeutics Product
Table 95. Novo Nordisk AS Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Novo Nordisk AS Recent Development
Table 97. Opiant Pharmaceuticals Inc. Company Details
Table 98. Opiant Pharmaceuticals Inc. Business Overview
Table 99. Opiant Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Opiant Pharmaceuticals Inc. Recent Development
Table 101. Pfizer Inc. Company Details
Table 102. Pfizer Inc. Business Overview
Table 103. Pfizer Inc. Addictions Therapeutics Product
Table 104. Pfizer Inc. Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Pfizer Inc. Recent Development
Table 106. Teva Pharmaceutical Industries Ltd. Company Details
Table 107. Teva Pharmaceutical Industries Ltd. Business Overview
Table 108. Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Product
Table 109. Teva Pharmaceutical Industries Ltd. Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Teva Pharmaceutical Industries Ltd. Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Addictions Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Alcohol Addiction Therapeutics Features
Figure 3. Tobacco Addiction Therapeutics Features
Figure 4. Drug Addiction Therapeutics Features
Figure 5. Global Addictions Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Public Case Studies
Figure 7. Private Case Studies
Figure 8. Government Case Studies
Figure 9. Addictions Therapeutics Report Years Considered
Figure 10. Global Addictions Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Addictions Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Addictions Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Addictions Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Addictions Therapeutics Market Share by Players in 2020
Figure 15. Global Top Addictions Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Addictions Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Addictions Therapeutics Revenue in 2020
Figure 17. Global Addictions Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Addictions Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Addictions Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Addictions Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Addictions Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Addictions Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Addictions Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Addictions Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Addictions Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Addictions Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Addictions Therapeutics Market Share by Region (2016-2027)
Figure 39. China Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Addictions Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Addictions Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Addictions Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Addictions Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Addictions Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Addictions Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Alkermes Plc Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
Figure 59. Amneal Pharmaceuticals Inc. Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
Figure 60. Indivior Plc Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
Figure 61. Johnson & Johnson Services Inc. Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
Figure 62. Mylan NV Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
Figure 63. Novartis AG Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
Figure 64. Novo Nordisk AS Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
Figure 65. Opiant Pharmaceuticals Inc. Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
Figure 66. Pfizer Inc. Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
Figure 67. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界のアルコール依存症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Alcohol Addiction Therapeutics Market The global Alcohol Addiction Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…- 世界の薬物乱用治療薬市場規模・現状・予測（2021年-2027年） Substance Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market …
- 世界の脾腫治療薬市場規模・現状・予測（2021年-2027年） Splenomegaly is an enlargement of the spleen.The spleen usually lies in the left upper quadrant (LUQ) of the human abdomen. Splenomegaly is one of the four cardinal signs of hypersplenism which include: some reduction in number of circulating blood cells affecting granulocytes, erythrocytes or plate…
- 世界のCOPD治療薬市場規模・現状・予測（2021年-2027年） Chronic Obstructive Pulmonary Disease (COPD) is a progressive disorder associated with chronic inflammation of the airways and lungs. Persistent breathing difficulties and repeated exacerbations of COPD symptoms make the disease one of the leading causes of morbidity, and the fifth-leading cause of …
- 世界のロタウイルス感染症治療薬市場規模・現状・予測（2021年-2027年） Rotavirus (RV) is a double-stranded ribonucleic acid virus, which belongs to the reovirus family. It is the single leading cause of diarrhea in infants and young children, and almost every child in the world around the age of five has been infected with rotavirus at least once. Market Analysis and I…